This company listing is no longer active
AS HansaMatrix Valuation
Is HMX1R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HMX1R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HMX1R (€8.46) is trading below our estimate of fair value (€10.36)
Significantly Below Fair Value: HMX1R is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HMX1R?
Other financial metrics that can be useful for relative valuation.
| What is HMX1R's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | €15.54m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.1x |
| Enterprise Value/EBITDA | 28.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does HMX1R's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.3x | ||
SAF1R SAF Tehnika | 0.6x | n/a | €18.5m |
NEON Neonode | 6.6x | 28.2% | US$29.3m |
8218 Echo International Holdings Group | 2x | n/a | HK$113.3m |
1967 Confidence Intelligence Holdings | 0.2x | n/a | HK$60.5m |
HMX1R AS HansaMatrix | 0.6x | 14.1% | €15.5m |
Price-To-Sales vs Peers: HMX1R is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (1.2x).
Price to Earnings Ratio vs Industry
How does HMX1R's PE Ratio compare vs other companies in the European Electronic Industry?
Price-To-Sales vs Industry: HMX1R is good value based on its Price-To-Sales Ratio (0.6x) compared to the European Electronic industry average (1.1x)
Price to Sales Ratio vs Fair Ratio
What is HMX1R's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.6x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate HMX1R's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Apr ’25 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Mar ’25 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Feb ’25 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Jan ’25 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Dec ’24 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Nov ’24 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Oct ’24 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Sep ’24 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Aug ’24 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Jul ’24 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Jun ’24 | n/a | €12.40 0% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| May ’24 | €8.36 | €12.40 +48.3% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Apr ’24 | €8.18 | €12.40 +51.6% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Mar ’24 | €8.20 | €12.40 +51.2% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Feb ’24 | €6.98 | €12.40 +77.7% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Jan ’24 | €6.98 | €12.40 +77.7% | 26.6% | €15.70 | €9.10 | n/a | 2 |
| Dec ’23 | €6.86 | €12.29 +79.2% | 27.7% | €15.70 | €8.88 | n/a | 2 |
| Nov ’23 | €5.98 | €12.29 +105.5% | 27.7% | €15.70 | €8.88 | n/a | 2 |
| Oct ’23 | €6.50 | €12.29 +89.1% | 27.7% | €15.70 | €8.88 | n/a | 2 |
| Sep ’23 | €6.88 | €12.29 +78.6% | 27.7% | €15.70 | €8.88 | n/a | 2 |
| Aug ’23 | €6.68 | €12.29 +84.0% | 27.7% | €15.70 | €8.88 | n/a | 2 |
| Jul ’23 | €6.50 | €12.29 +89.1% | 27.7% | €15.70 | €8.88 | n/a | 2 |
| Jun ’23 | €7.22 | €13.40 +85.6% | 17.2% | €15.70 | €11.10 | n/a | 2 |
| May ’23 | €7.08 | €13.41 +89.4% | 17.1% | €15.70 | €11.12 | €8.36 | 2 |
| Apr ’23 | €7.40 | €13.41 +81.2% | 17.1% | €15.70 | €11.12 | €8.18 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.